Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eugenia Cella"'
Autor:
Camilla Satragno, Irene Schiavetti, Eugenia Cella, Federica Picichè, Laura Falcitano, Martina Resaz, Monica Truffelli, Stefano Caneva, Pietro Mattioli, Daniela Esposito, Alessio Ginulla, Claudio Scaffidi, Pietro Fiaschi, Alessandro D’Andrea, Andrea Bianconi, Gianluigi Zona, Laura Barletta, Luca Roccatagliata, Lucio Castellan, Silvia Morbelli, Matteo Bauckneht, Isabella Donegani, Paolo Nozza, Dario Arnaldi, Giulia Vidano, Flavio Gianelli, Salvina Barra, Elisa Bennicelli, Liliana Belgioia
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100849- (2024)
Background: High-grade glioma (HGG) patients post-radiotherapy often face challenges distinguishing true tumor progression (TTP) from pseudoprogression (PsP). This study evaluates the effectiveness of systemic inflammatory markers and volume of enhan
Externí odkaz:
https://doaj.org/article/967fdd8b118e453ab4bbe5e61d5fd059
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 4090 (2024)
Glioblastoma (GBM) is the most aggressive malignant primary central nervous system (CNS) tumor and, despite decades of research, it remains a lethal disease with a median overall survival of less than two years [...]
Externí odkaz:
https://doaj.org/article/bed5437c0cf64aa9b3ce5d6478339afb
Autor:
Carlo Genova, Roberta Tasso, Alessandra Rosa, Giovanni Rossi, Daniele Reverberi, Vincenzo Fontana, Silvia Marconi, Michela Croce, Maria Giovanna Dal Bello, Chiara Dellepiane, Marco Tagliamento, Maria Chiara Ciferri, Lodovica Zullo, Alessandro Fedeli, Angela Alama, Katia Cortese, Chiara Gentili, Eugenia Cella, Giorgia Anselmi, Marco Mora, Giulia Barletta, Erika Rijavec, Francesco Grossi, Paolo Pronzato, Simona Coco
Publikováno v:
Cells, Vol 12, Iss 6, p 832 (2023)
The treatment of non-small cell lung cancer (NSCLC) has changed dramatically with the advent of immune checkpoint inhibitors (ICIs). Despite encouraging results, their efficacy remains limited to a subgroup of patients. Circulating immune checkpoints
Externí odkaz:
https://doaj.org/article/1ae01a3f739d4d27868c612a121bdfb1
Autor:
Silvia Morbelli, Dario Arnaldi, Eugenia Cella, Stefano Raffa, Maria Isabella Donegani, Selene Capitanio, Federico Massa, Alberto Miceli, Laura Filippi, Andrea Chincarini, Flavio Nobili
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Purpose Our aim was to compare a widely distributed commercial tool with an older free software (i) one another, (ii) with a clinical motor score, (iii) versus reading by experts. Procedures We analyzed consecutive scans from one-hundred and
Externí odkaz:
https://doaj.org/article/f1fdd99a3911492f809b6432e920a31e
Autor:
Eugenia Cella, Lodovica Zullo, Silvia Marconi, Giovanni Rossi, Simona Coco, Chiara Dellepiane, Angela Alama, Leslie Rozeboom, Elisa Bennicelli, Francesca Parisi, Gianluca Sacco, Giulia Barletta, Linda Zinoli, Marco Tagliamento, Paolo Pronzato, Carlo Genova
Publikováno v:
Expert Opinion on Biological Therapy. 22:1259-1273
In recent years, immunotherapy has become a pillar in the treatment of advanced, non-oncogene-addicted non-small cell lung cancer (NSCLC). Programmed death ligand 1 (PD-L1) expression is currently the only factor used to predict response to immunothe
Publikováno v:
AME Surgical Journal. 3:5-5
Autor:
Francesca Parisi, Giovanni Rossi, Federica Biello, Marco Tagliamento, Giulia Barletta, Lodovica Zullo, Eugenia Cella, Gianluca Sacco, Chiara Dellepiane, Elisa Bennicelli, Diletta Favero, Angela Alama, Simona Coco, Silvia Marconi, Linda Zinoli, Enrica Teresa Tanda, Paolo Pronzato, Erika Rijavec, Carlo Genova
Publikováno v:
Precision Cancer Medicine. 5:25-25
Autor:
Filippo Gustavo Dall'Olio, Camilo Garcia, Valentina Ambrosini, Marco Tagliamento, Carole Helissey, Monica Velasco, Mohamed Aymen Bettayeb, Mihaela Aldea, Nicole Conci, Matteo Bauckneht, Gerald Bonardel, Giulia Argalia, Davide Soldato, Eugenia Cella, Jordi Remon Masip, David Planchard, Corinne Balleyguier, Andrea Ardizzoni, Fabrice Barlesi, Benjamin Besse
Publikováno v:
Journal of Clinical Oncology. 40:9062-9062
9062 Background: Upfront Immune Checkpoint Blockers (ICB) alone or in combination with chemotherapy (CT) have become the backbone treatment of non-oncogene addicted aNSCLC. PD-L1 remains the only predictive biomarker, but additional biomarkers are ma
Autor:
Dario Arnaldi, Silvia Morbelli, Stefano Raffa, Selene Capitanio, Federico Massa, Laura Filippi, Andrea Chincarini, Maria Isabella Donegani, Alberto Miceli, Eugenia Cella, Flavio Nobili
Publikováno v:
EJNMMI Research
EJNMMI Research, Vol 10, Iss 1, Pp 1-8 (2020)
EJNMMI Research, Vol 10, Iss 1, Pp 1-8 (2020)
Purpose Our aim was to compare a widely distributed commercial tool with an older free software (i) one another, (ii) with a clinical motor score, (iii) versus reading by experts. Procedures We analyzed consecutive scans from one-hundred and fifty-on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eacd0138fc3d49c96d25416ce36fb5de
https://doi.org/10.21203/rs.3.rs-38885/v3
https://doi.org/10.21203/rs.3.rs-38885/v3